Device therapy for cardiac arrhythmias

JAMA

Volumn 287, Issue 14, 2002, Pages 1848-1852

  Kusumoto, Fred M ^a   Goldschlager, Nora ^a,b  

^a LOVELACE MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIOMYOPATHY; CARDIOVERSION; CLINICAL TRIAL; DEFIBRILLATION; DEFIBRILLATOR; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART FAILURE; HEART PACING; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; SINUS NODE DISEASE; SYNCOPE; TREATMENT INDICATION;

EID: 0037051985     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.14.1848     Document Type: Review

References (26)

1. Survey of cardiac pacing and implanted defibrillator practice patterns in the United States in 1997
2. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implanttation)
3. Cardiac rhythm management devices: Part 1
4. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction
5. Indications for internal cardioverter defibrillators
6. Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia
7. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay
8. MIRACLE trial data
9. Long-term results of dual chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy
10. Assessment of dual-chamber pacing as a treatment for drug refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: A randomized, double-blind, crossover study (M-PATHY)
11. Pacing in hypertrophic cardiomyopathy
12. The North American vasovagal pacemaker study: A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope
13. Dualchamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope
14. Carotid sinus syndrome: A modifiable risk factor for nonaccidental falls in older adults (SAFE PACE)
15. DAPPAF trial data
16. Longterm follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome
17. Progression to chronic atrial fibrillation after pacing: The Canadian Trial of Physiologic Pacing
18. MOST trial data
19. The United Kingdom Pacing and Cardiovascular Events (UKPACE) trial
20. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death
21. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
22. A randomized study of the prevention of sudden death in patients with coronary artery disease
23. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction
24. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
25. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
26. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator